Previous studies indicated that elevated expression of FBLN1 is associated with cancer progression, including hepatocellular carcinoma, cholangiocarcinoma, and renal cell carcinoma (Xiao et al., 2013; Jie et al., 2019; Gong et al., 2020). The gene discussed is FBLN1; the disease is renal cell carcinoma.